Mimedx (MDXG) Return on Capital Employed Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -494.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -649.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4,853.00 |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | 1,856.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,856.00 |
| Dec 31, 2025 | 3,542.00 |
| Sep 30, 2025 | 4,160.00 |
| Jun 30, 2025 | 3,252.00 |
| Mar 31, 2025 | 3,058.00 |
| Dec 31, 2024 | 3,323.00 |
| Sep 30, 2024 | 4,964.00 |
| Jun 30, 2024 | 5,791.00 |
| Mar 31, 2024 | 5,423.00 |
| Dec 31, 2023 | 5,266.00 |
| Sep 30, 2023 | 5,106.00 |
| Jun 30, 2023 | 2,277.00 |
| Mar 31, 2023 | 1,716.00 |
| Dec 31, 2022 | 853.00 |
| Sep 30, 2022 | 506.00 |
| Jun 30, 2022 | 5,033.00 |
| Mar 31, 2022 | 3,337.00 |
| Dec 31, 2020 | -7,494.00 |
| Sep 30, 2020 | -3,607.00 |
| Jun 30, 2020 | -1,775.00 |
| Mar 31, 2020 | -2,706.00 |
| Dec 31, 2019 | -2,098.00 |
| Sep 30, 2019 | -3,757.00 |
| Jun 30, 2019 | -7,832.00 |
| Mar 31, 2019 | -5,684.00 |
| Dec 31, 2017 | 3,601.00 |
| Sep 30, 2017 | 735.00 |
| Jun 30, 2017 | 1,033.00 |
| Mar 31, 2017 | 975.00 |
| Dec 31, 2016 | 576.00 |
| Sep 30, 2016 | 1,907.00 |
| Jun 30, 2016 | 3,101.00 |
| Mar 31, 2016 | 3,311.00 |
| Dec 31, 2015 | 4,165.00 |
| Sep 30, 2015 | 5,643.00 |
| Jun 30, 2015 | 4,576.00 |
| Mar 31, 2015 | 4,908.00 |
| Dec 31, 2014 | 5,577.00 |